CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead? Nitrosative stress drives heart failure with preserved ejection fraction Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure HFpEF: From Mechanisms to Therapies Heart Failure With Preserved Ejection Fraction in the Young Functional Impairment and Medication Burden in Adults With Heart Failure

Expert Opinion03 January 2021

JOURNAL:Eur Heart J. Article Link

The year in cardiovascular medicine 2020: heart failure and cardiomyopathies

H Bueno, B Moura, P Lancellotti et al. Keywords: heart failure; cardiomyopathies

Full Text PDF